Inventor · disambiguated record
Yu Gui Gu
Also filed as: GU YU G · GU YU GUI · GU Yu
26 granted patents·14 pending applications·157 citations·filing 1996–2023
95Inventor score
Top patents by PatentIndex Score
40 records- 0193US8809314B1Cephalosporin compoundCUBIST PHARM INC·Filed 2013·Granted Aug 19, 2014·16 cites·7 claims
- 0291US6455571B1Inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Sep 24, 2002·60 cites·115 claims
- 0388US8962843B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·3 cites·5 claims
- 0486US8916709B21,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 0583US8969570B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Mar 3, 2015·3 cites·15 claims
- 0682US8940897B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 27, 2015·1 cites·5 claims
- 0782US8933233B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 0882US8933232B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 0982US8927724B2Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 6, 2015·3 cites·39 claims
- 1081US8962844B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·1 cites·5 claims
- 1181US7928243B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeABBOTT LAB·Filed 2007·Granted Apr 19, 2011·4 cites·11 claims
- 1280US9193729B2Inhibiting transient receptor potential ion channel TRPA1CUBIST PHARM INC·Filed 2013·Granted Nov 24, 2015·6 cites·11 claims
- 1379US8748627B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeGU YU GUI·Filed 2007·Granted Jun 10, 2014·6 cites·29 claims
- 1475US8207350B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeKEYES ROBERT F·Filed 2008·Granted Jun 26, 2012·4 cites·25 claims
- 1574US6593314B1Neuraminidase inhibitorsABBOTT LAB·Filed 2000·Granted Jul 15, 2003·8 cites·15 claims
- 1672US2015031659A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 1769US6831096B2Inhibitors of neuraminidasesABBOTT LAB·Filed 2002·Granted Dec 14, 2004·3 cites·9 claims
- 1869US6030969A5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compoundsABBOTT LAB·Filed 1998·Granted Feb 29, 2000·14 cites·16 claims
- 1968US2015031665A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2067US2015031666A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2167US2015038478A1Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2266US9108966B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Granted Aug 18, 2015·0 cites·3 claims
- 2365US2014323459A1Isoxazole beta-lactamase inhibitorsCALIXA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2464US6992069B2Tricyclic macrolide antibacterial compoundsGU YU-GUI·Filed 2003·Granted Jan 31, 2006·2 cites·22 claims
- 2564US2025197448A1Cyclopeptibodies and uses thereofUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 2664US2015031660A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 2763US7196200B2Antibacterial compoundsABBOTT LAB·Filed 2004·Granted Mar 27, 2007·2 cites·7 claims
- 2860US5668141ATrans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonistsABBOTT LAB·Filed 1996·Granted Sep 16, 1997·8 cites·24 claims
- 2960US2015025053A1Cephalosporin compoundCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3058US7737159B2Antibacterial compoundsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·0 cites·5 claims
- 3157US2015038479A1Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3255US6518305B1Five-membered carbocyclic and heterocyclic inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Feb 11, 2003·6 cites·110 claims
- 3354US8163769B2Antibacterial compoundsANDERSON DAVID·Filed 2003·Granted Apr 24, 2012·1 cites·19 claims
- 3454US2015038482A1Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3550US2014158116A1Inhibiting trpa1 for the treatment of asthmaCUBIST PHARM INC·Filed 2013·Application pending·0 cites
- 3648US2007219258A1Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndromeKEYES ROBERT F·Filed 2007·Application pending·0 cites
- 3747US2014315876A1Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3844US8735595B2Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeGU YU GUI·Filed 2007·Granted May 27, 2014·0 cites·16 claims
- 3944US2006178400A1Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndromeBEUTEL BRUCE A·Filed 2005·Application pending·0 cites
- 4039US6818654B2Antibacterial compoundsABBOTT LAB·Filed 2003·Granted Nov 16, 2004·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yu Gui Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →